CONNECT WITH US:
Global BioLife's new mosquito repellent formula performs well against mosquitos in independent testing
Jun 12, 2019 14:00 JST
Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has independently tested a new mosquito repellent formula which performs well against mosquitos for six (6) to eight (8) hours.
Singapore eDevelopment subsidiary Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
Jan 28, 2019 12:00 JST
SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis.
Singapore eDevelopment Subsidiary, Global BioLife, Proudly Announces Presentation of Parkinson's Research at Neuroscience 2018
Nov 07, 2018 19:00 JST
Singapore eDevelopment (SGX: 40V) ("SeD") subsidiary, Global BioLife Inc. is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California.
Singapore eDevelopment Announces Corporate and Business Update
Jun 18, 2018 19:00 JST
The Board of Directors of Singapore eDevelopment Limited wishes to provide shareholders an update on the Group's operations.
Singapore Exchange-Listed Singapore eDevelopment Limited's U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified Sugar
May 31, 2018 18:00 JST
Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market.
Singapore eDevelopment biomedical subsidiary confirms LB2 efficacy against Ebola
Mar 01, 2018 14:00 JST
Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker.
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% Repellency of 3F Mosquito Fragrance
Nov 01, 2017 18:00 JST
Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife") has completed development and testing of mosquito deterring technologies including fragrances, paints, and fabric.
SGX-Listed Singapore eDevelopment's Global BioLife Inc Develops Breakthrough Modified Sugar
Oct 24, 2017 18:00 JST
SGX-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"), has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market.
Singapore eDevelopment's Global BioLife and U.S.-based Chemia Corporation to Develop Functional Fragrances to Fight Mosquito-Borne Diseases
Aug 15, 2017 19:00 JST
Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications.
First-Year Performance of Global Systematic Multi-Strategy Fund
Jun 15, 2017 10:15 JST
The Board of Directors of Singapore eDevelopment Ltd ("SeD") wishes to announce that its Global Systematic Multi-Strategy Fund ("GSMS Fund") managed by Hengfai Asset Management Pte Ltd ("HFAM"), a wholly owned subsidiary of SeD's investment-arm SeD Capital Pte Ltd, achieved a gross and net return of 15% and 10%, respectively, in its first year of operation.
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
May 22, 2017 11:00 JST
Singapore eDevelopment Limited ("SeD"), through its subsidiary, Global BioLife Inc. ("Global BioLife") has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer.
Toyota Provides Diverse Mobility for Tokyo 2020, including a Full Line-up of Electrified Vehicles
Aug 23, 2019 16:58 JST
NEC Receives Order for Intelligent Transportation System in Makkah, Saudi Arabia
Aug 23, 2019 11:42 JST
MHI to Exhibit at the Japan-Africa Business Expo during TICAD7
Aug 22, 2019 14:20 JST
Fujitsu and Qualcomm Complete 5G Data Calls in Sub-6 GHz and mmWave Spectrum Bands
Aug 22, 2019 11:13 JST
NEC: Industrial Internet Consortium Approves Testbed of Negotiation Automation Platform for coordinating interests among AI systems
Aug 21, 2019 11:24 JST
NEC to Install More than 20MW of Municipal Energy Storage Projects in New England
Aug 21, 2019 11:01 JST
Fernando Alonso Keeps an Eye on Dakar with TOYOTA GAZOO Racing
Aug 20, 2019 17:06 JST
MHIEC Receives Order to Refurbish the Hiroshima Naka Waste to Energy Plant
Aug 20, 2019 11:10 JST
New Combustor Center for Manufacturing Aero Engine Parts to be Established within MHI's Nagasaki Shipyard & Machinery Works
Aug 19, 2019 12:49 JST
Toyota Yaris WRC Ready to Master the Varied Roads of Germany
Aug 16, 2019 20:13 JST
Fujitsu Develops AI Disaster Mitigation Technology to Predict River Flooding with Limited Data
Aug 16, 2019 14:15 JST
ULVAC Launches Revolutionary PZT Piezoelectric Thin-film Process Technology and HVM Solution for MEMS Sensors/Actuators
Aug 16, 2019 14:00 JST
Honda Announces Changes in Production Operations in Argentina
Aug 14, 2019 09:04 JST
The HondaJet is the Most Delivered Aircraft in its Class for the First Half of 2019
Aug 13, 2019 10:47 JST
Notice of Signing Basic Agreements for Airport Operation of the Seven Airports in Hokkaido
Aug 09, 2019 17:05 JST
MHI Developing the QoEn Index for Energy Infrastructure to Support the Sustainable Growth of Society
Aug 09, 2019 14:04 JST
Fujitsu Initiates Year-Round Recruitment
Aug 09, 2019 11:27 JST
Mitsubishi Motors to Introduce its Customers to a New Energy Plan by MC Retail Energy
Aug 08, 2019 19:20 JST
Fujitsu RunMyProcess Joins Google Cloud Partner Program
Aug 08, 2019 09:00 JST
SDK Revises 2019 Consolidated Performance Forecast
Aug 07, 2019 16:05 JST
More Latest Release >>